• 1. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 2. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Aminoquinolines and derivatives

6-Chloroquinolin-3-amine (CAS No. 1051372-60-1): An Overview of Its Structure, Properties, and Applications in Medicinal Chemistry

6-Chloroquinolin-3-amine (CAS No. 1051372-60-1) is a versatile compound with significant potential in the field of medicinal chemistry. This article provides a comprehensive overview of its chemical structure, physical and chemical properties, and its applications in various research areas, including drug discovery and development.

Chemical Structure and Properties: 6-Chloroquinolin-3-amine is a substituted quinoline derivative characterized by a chlorine atom at the 6-position and an amino group at the 3-position. The molecular formula of this compound is C₉H₈ClN₂, with a molecular weight of approximately 187.63 g/mol. The presence of the amino group imparts basic properties to the molecule, making it capable of forming salts with acids.

The compound exhibits good solubility in organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF), but it is sparingly soluble in water. This solubility profile makes it suitable for use in various biological assays and chemical reactions. Additionally, 6-Chloroquinolin-3-amine has a melting point of around 155°C, which is an important consideration for handling and storage.

Synthesis and Preparation: The synthesis of 6-Chloroquinolin-3-amine can be achieved through several routes, but one common method involves the reaction of 2-chloroaniline with ethyl acetoacetate followed by cyclization under acidic conditions. Another approach involves the reaction of 2-chlorobenzyl chloride with ammonia to form the corresponding amine, which is then cyclized to form the quinoline ring. These synthetic methods are well-documented in the literature and provide researchers with flexible options for large-scale production.

Biological Activity and Applications: Recent studies have highlighted the potential of 6-Chloroquinolin-3-amine as a lead compound in drug discovery. One notable area of research is its activity as an inhibitor of specific enzymes involved in various disease pathways. For instance, it has been shown to inhibit the activity of kinases, which are key regulators of cellular signaling pathways implicated in cancer and inflammatory diseases.

In a study published in the Journal of Medicinal Chemistry, researchers demonstrated that 6-Chloroquinolin-3-amine derivatives exhibit potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. This finding suggests that these compounds could be valuable candidates for the development of new anti-inflammatory drugs.

Beyond its anti-inflammatory properties, 6-Chloroquinolin-3-amine has also shown promise as an antiparasitic agent. In vitro studies have demonstrated its efficacy against parasitic infections such as malaria and leishmaniasis. The mechanism of action involves disruption of parasitic metabolism and inhibition of essential enzymes required for parasite survival.

Clinical Trials and Development: While 6-Chloroquinolin-3-amine itself may not be directly used as a drug, its derivatives are actively being investigated in preclinical and clinical trials. Several pharmaceutical companies are exploring its potential as a scaffold for developing novel therapeutics targeting various diseases. For example, a phase I clinical trial evaluating a derivative of 6-Chloroquinolin-3-amine for the treatment of chronic inflammatory diseases showed promising results in terms of safety and efficacy.

Safety Considerations: As with any chemical compound used in research or drug development, safety is a critical consideration. Preclinical studies have indicated that 6-Chloroquinolin-3-amine has low toxicity at therapeutic concentrations. However, it is important to handle this compound with care, following standard laboratory safety protocols to minimize exposure risks.

FUTURE DIRECTIONS AND CONCLUSIONS: The ongoing research on 6-Chloroquinolin-3-amine and its derivatives highlights its potential as a valuable tool in medicinal chemistry. Further studies are needed to fully elucidate its mechanism of action, optimize its pharmacological properties, and explore new therapeutic applications. As our understanding of this compound continues to evolve, it is likely to play an increasingly important role in the development of novel therapeutics for various diseases.

• 23045-20-7(2-Acridinamine,7-chloro-)
• 81764-16-1(4-Chloroquinolin-8-amine)
• 5470-75-7(6-Chloro-8-aminoquinoline)
• 5432-09-7(5-Chloroquinolin-8-amine)
• 347146-21-8(8-Chloroquinolin-3-amine)
• 1416437-91-6(5-chloroquinolin-3-amine)
• 6338-98-3(7-Chloroquinolin-8-amine)
• 1195710-15-6(7-Chloroquinolin-3-amine)
• 72561-51-4(5-Chloro-1H-indol-3-amine)
• 139399-66-9(3-Chloroquinolin-8-amine)